Today: 21 July 2026
Fermi Inc stock slides 10% on fresh class-action filing headlines, with Evercore conference next
7 January 2026
1 min read

Fermi Inc stock slides 10% on fresh class-action filing headlines, with Evercore conference next

New York, January 7, 2026, 13:24 (EST) — Regular session

  • Fermi shares fell about 11% in afternoon trade, extending sharp swings since December
  • Plaintiff firms circulated notices of a securities class action tied to the IPO and Project Matador disclosures
  • Investors are watching an Evercore conference appearance on Jan. 8 for any update on tenants and funding

Shares of Fermi Inc (FRMI.O) slid on Wednesday, last down $1.01, or about 10.6%, at $8.50. The stock hit an intraday low of $8.37 and had traded about 5.6 million shares.

The move came as plaintiffs’ firms pushed fresh notices around a proposed securities class action lawsuit, reopening questions about how Fermi pitched demand and funding for its Project Matador campus in Texas. Glancy Prongay & Murray said the case targets investors who bought stock in or traceable to the October IPO, priced at $21 a share, or bought securities during the alleged class period.

The complaint was filed on Jan. 5 and runs through Dec. 11, according to Hagens Berman, which posted the filing on its website. It ties the claims to Fermi’s disclosure that its first prospective tenant terminated an “advance in aid of construction” agreement — a funding pact that would have brought up to $150 million to help pay for construction. Hagens Berman

Fermi shares plunged about 34% on Dec. 12 after the company said the tenant had ended the funding deal for Project Matador. Brian Jacobsen, chief economist at Annex Wealth Management, said at the time that “key person and key client risk” sat at the center of the story. Reuters

Fermi bills itself as an advanced-energy and hyperscale developer building private grids to power artificial intelligence data centers. Project Matador sits on a 5,236-acre site in Amarillo, Texas, on land leased from the Texas Tech University System, and is designed to accommodate up to 6 gigawatts of nuclear capacity, Reuters data show.

The company has also tried to tamp down speculation about the identity of the would-be tenant. In December, a company spokesperson told Reuters it “categorically” denied a report that Amazon was the prospective tenant that withdrew funding. Reuters

But the stock is still trading on headlines, not cash flow. Any delay in lining up tenants, or a new turn in the litigation, could keep pressure on the shares and complicate financing for the build.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Cadiz, ArriVent BioPharma, Acco Brands join Zacks Strong Sell list for July 21st
    July 21, 2026, 6:12 AM EDT. Cadiz (CDZI), ArriVent BioPharma (AVBP), and Acco Brands (ACCO) were added to the Zacks Rank #5 (Strong Sell) List. Cadiz's earnings estimate tumbled 40%, while ArriVent BioPharma slipped 7.3% and Acco Brands dropped 5.1% in consensus earnings over the past 60 days. These moves mark a significant slide in expected earnings for July 21st.
NIO stock today: Shares slide in premarket after record 2025 deliveries
Previous Story

NIO stock today: Shares slide in premarket after record 2025 deliveries

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14
Next Story

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Go toTop